Compugen Ltd. Depreciation & Amortization 2011-2026 | CGEN

Annual Depreciation & Amortization Compugen Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	461 K	715 K	989 K	1.39 M	1.59 M	1.48 M	1.11 M	658 K	370 K	299 K	179 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.59 M	179 K	841 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Assembly Biosciences ASMB	129 K	$ 28.49	0.11 %	$ 319 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 19.61	0.59 %	$ 917 M	USA
Amarin Corporation plc AMRN	3.02 M	$ 14.72	1.59 %	$ 6.11 B	Irlanda
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	7.55 M	$ 1.4	1.82 %	$ 357 M	Britain
Axsome Therapeutics AXSM	503 K	$ 155.38	-0.98 %	$ 7.73 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
BioMarin Pharmaceutical BMRN	79.6 M	$ 55.05	1.7 %	$ 10.6 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	18.4 M	$ 3.46	1.76 %	$ 1.03 B	Canada
Benitec Biopharma BNTC	66 K	$ 10.92	-0.55 %	$ 449 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Heron Therapeutics HRTX	2.31 M	$ 0.79	2.02 %	$ 132 M	USA
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Coherus BioSciences CHRS	1.3 M	$ 1.58	3.62 %	$ 185 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	1.4 M	$ 4.47	5.54 %	$ 742 M	Canada
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	6 K	-	-5.98 %	$ 34.1 M	USA
Decibel Therapeutics DBTX	1.5 M	-	-	$ 123 M	USA